ANGO stock news

ANGO stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-13 17:19:00 UTC#453998updateconfirmednews

H.C. Wainwright cuts AngioDynamics (ANGO) price target to $18.00 from $19.00

dow_jonesimportance 0.30trust 0.70AngioDynamics, Inc. -0.30H.C. Wainwright & Co. -0.20

2026-10-13 17:08:56 UTC#453955newconfirmednews

HC Wainwright maintains Buy rating on AngioDynamics, sets $18 price target

tradingviewimportance 0.40trust 0.70H.C. Wainwright & Co. +0.20AngioDynamics, Inc. +0.40

2026-10-09 12:31:48 UTC#438245newconfirmednews

Canaccord Genuity maintains Buy rating on AngioDynamics, sets $20 price target

tradingviewimportance 0.30trust 0.60AngioDynamics, Inc. +0.40Canaccord Genuity Group Inc. +0.30

2026-10-08 22:00:00 UTC#435485duplicateconfirmednews

Upcoming Earnings Before Thursday Open: PepsiCo, AngioDynamics, Byrna, Helen of Troy, NovaGold, Tilray

seekingalpha.comimportance 0.30trust 0.80PepsiCo, Inc. 0AngioDynamics, Inc. 0Byrna Technologies Inc. 0+2 entities

2026-10-08 16:09:00 UTC#433728duplicateconfirmednews

AngioDynamics shares fall 20% following appointment of Eric Honroth as CEO

dow_jonesimportance 0.30trust 0.80AngioDynamics, Inc. -0.50Eric Honroth -0.20James Clemmer -0.10+1 entities

2026-10-08 15:25:56 UTC#433492updateconfirmednews

AngioDynamics projects FY2027 net sales of $336M-$341M as CEO transition nears

seeking alphaimportance 0.50trust 0.80AngioDynamics, Inc. +0.30

2026-10-08 13:33:14 UTC#432784duplicateconfirmednews

AngioDynamics Q1 adjusted loss of $0.04/share beats $0.11 loss estimate; revenue $80.92M beats $80.50M forecast

reutersimportance 0.30trust 0.80AngioDynamics, Inc. +0.30

2026-10-08 10:21:00 UTC#431264duplicateconfirmednews

AngioDynamics confirms Eric Honroth to succeed retiring CEO James Clemmer on Nov. 2

dow_jonesimportance 0.30trust 0.90AngioDynamics, Inc. 0Eric Honroth +0.10James Clemmer 0+1 entities

2026-10-08 10:08:09 UTC#431163duplicateconfirmednews

AngioDynamics Q1 Results Beat Estimates, FY26 Outlook Reaffirmed

seeking alphaimportance 0.30trust 0.70AngioDynamics, Inc. +0.50

2026-10-08 10:03:00 UTC#431076newconfirmednews

AngioDynamics Q1 Revenue $80.9M Beats Estimates; FY Sales Outlook $336-341M, Adjusted EPS -$0.29 to -$0.24

reutersimportance 0.40trust 0.90AngioDynamics, Inc. -0.20

2026-10-08 10:02:00 UTC#431103duplicateconfirmednews

AngioDynamics Q1 Sales $80.9M, +6.9% YoY; Eric Honroth Named CEO Effective Nov. 2

tradingviewimportance 0.40trust 0.70AngioDynamics, Inc. +0.30Eric Honroth +0.20

2026-10-08 10:02:00 UTC#431085duplicateconfirmednews

AngioDynamics Reports Fiscal Q1 Loss of $0.17 Per Share

dow_jonesimportance 0.30trust 0.90AngioDynamics, Inc. -0.40

2026-10-08 10:02:00 UTC#431080updateconfirmednews

AngioDynamics Reports $7.1M Net Loss for Fiscal Q1 2027

dow_jonesimportance 0.40trust 0.90AngioDynamics, Inc. -0.30

2026-10-08 10:02:00 UTC#431077updateconfirmednews

AngioDynamics Reports Q1 Adjusted EPS of 4c

dow_jonesimportance 0.40trust 0.90AngioDynamics, Inc. +0.20

2026-10-08 10:00:00 UTC#431151duplicateconfirmednews

AngioDynamics CEO Jim Clemmer to retire; Eric Honroth named successor

dow_jonesimportance 0.30trust 0.90AngioDynamics, Inc. -0.10Jim Clemmer -0.10

2026-10-08 10:00:00 UTC#431148duplicateconfirmednews

AngioDynamics appoints Eric Honroth as CEO effective Nov. 2, 2026, succeeding Jim Clemmer

tradingviewimportance 0.40trust 0.80AngioDynamics, Inc. +0.20Eric Honroth +0.20Jim Clemmer 0

2026-10-08 10:00:00 UTC#431145newconfirmednews

Upcoming US Earnings Calendar: PepsiCo, Delta Air Lines, Helen of Troy, and Others Report This Week

dow_jonesimportance 0.40trust 0.90AngioDynamics, Inc. 0Byrna Technologies Inc. 0Helen of Troy Limited 0+2 entities

2026-10-07 18:51:05 UTC#427774newforecastnews

AngioDynamics Q1 2027 Earnings Preview

seeking alphaimportance 0.30trust 0.60AngioDynamics, Inc. 0

2026-10-07 11:00:02 UTC#424961newforecastnews

AngioDynamics (ANGO) Q1'26 Earnings Preview: Revenue Estimate $80.51M, EPS Estimate ($0.11)

tradingviewimportance 0.30trust 0.70AngioDynamics, Inc. 0

2026-10-01 11:00:00 UTC#397920newforecastnews

AngioDynamics (ANGO) Q1'26 Earnings Preview: Analysts Expect $80.51M Revenue and -$0.11 EPS

tradingviewimportance 0.30trust 0.70AngioDynamics, Inc. 0